Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_assertion description "[This study further provides a basis for clinical studies of the antisense oligonucleotide targeted to the RIalpha subunit of PKA (GEM 231) as a cancer therapeutic agent used alone or in combination with conventional chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_assertion evidence source_evidence_literature NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_assertion SIO_000772 10570186 NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_assertion wasDerivedFrom befree-20150227 NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_assertion wasGeneratedBy ECO_0000203 NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP422903.RAjHMPWDeFg57Rn_OFS4CoNVBfE4juOPg5L6BoMjZEiLU130_provenance.